Our Blog

Understanding ARIA – a recognised side-effect of new Alzheimer’s medications

ARIA, or Amyloid-Related Imaging Abnormalities, is a recognised side-effect of lecanemab (Lequembi™) and donanemab and other medications in the same class. These medications are monoclonal antibodies (MABs) […]

Understanding Lecanemab (Leqembi™): A Breakthrough in Alzheimer’s Treatment

Lecanemab, also known by its name Leqembi™, represents a significant milestone in the ongoing battle against Alzheimer’s disease. This innovative drug offers new hope to patients living […]

Giving Hope Through Clinical Trials – David’s Story

David was diagnosed with Alzheimer’s in 2016 after experiencing problems with his memory. Below he shares his story about joining the Clarity clinical trial at Re:Cognition Health, […]

A New Milestone in Alzheimer’s Treatment: MHRA Approves Lecanemab (Leqembi™)

PRESS RELEASE. Re:Cognition Health is delighted to offer this new treatment Re:Cognition Health is delighted with the announcement that the MHRA has approved Lecanemab, a pioneering treatment […]

Vision Loss and Cholesterol Linked to Dementia

The latest report from the Lancet Commission presents groundbreaking findings suggesting that treating failing eyesight and high cholesterol could be pivotal in lowering the risk of developing […]

The Potential of Ozempic in Treating Alzheimer’s and Depression: A Promising Horizon

Medications such as Ozempic and Wegovy, both of which contain Semaglutide, a GLP-1 receptor, were originally designed to treat type 2 diabetes and obesity, however, their potential […]

Building Cognitive Resilience: Strategies to Mitigate Brain Decline and Enhance Mental Health

Dr Emer MacSweeney, CEO, Founder and Consultant Neuroradiologist at Re:Cognition Health was featured in the Times newspaper giving her insight on various strategies for building a “cognitive […]

Understanding Concussions: Risks, Symptoms, and Recovery

Consultant Neurologist Dr Steve Allder was interviewed by the Telegraph for a feature about concussion and the long-term risks for people over 60. Below he shares an […]

Mastering Exam Stress: Expert Tips For Building Resilience And Confidence By Dr. Tom MacLaren

Exams can be a significant source of stress and anxiety for students at any level of education. However, with the right strategies, you can navigate these challenges […]

Medication For ADHD Linked To Lower Mortality Rates

Medication for ADHD Linked to Lower Mortality Rates Dr Tom MacLaren speaks with Healthline about the results A recent study conducted in Sweden has highlighted the potential […]